566 related articles for article (PubMed ID: 23428955)
21. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
[TBL] [Abstract][Full Text] [Related]
22. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
[TBL] [Abstract][Full Text] [Related]
23. Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.
de Azevedo Santos TR; Tundisi CF; Ramos H; Maia MA; Pellizzon AC; Silva ML; Fogaroli RC; Chen MJ; Suzuki SH; Dias JE; Sanematsu PI; de Castro DG
Radiat Oncol; 2015 Mar; 10():63. PubMed ID: 25884621
[TBL] [Abstract][Full Text] [Related]
24. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases.
Xu Z; Lee CC; Ramesh A; Mueller AC; Schlesinger D; Cohen-Inbar O; Shih HH; Sheehan JP
J Neurosurg; 2017 Mar; 126(3):726-734. PubMed ID: 27203149
[TBL] [Abstract][Full Text] [Related]
25. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
26. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
[TBL] [Abstract][Full Text] [Related]
27. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic radiosurgery for intraventricular brain metastases.
Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
[TBL] [Abstract][Full Text] [Related]
29. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
[TBL] [Abstract][Full Text] [Related]
30. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.
Koc M; McGregor J; Grecula J; Bauer CJ; Gupta N; Gahbauer RA
J Neurooncol; 2005 Feb; 71(3):307-13. PubMed ID: 15735922
[TBL] [Abstract][Full Text] [Related]
31. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
[TBL] [Abstract][Full Text] [Related]
32. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
33. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
[TBL] [Abstract][Full Text] [Related]
35. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.
Gaudy-Marqueste C; Regis JM; Muracciole X; Laurans R; Richard MA; Bonerandi JJ; Grob JJ
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):809-16. PubMed ID: 16682138
[TBL] [Abstract][Full Text] [Related]
36. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
[TBL] [Abstract][Full Text] [Related]
37. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
38. Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience.
Gonzalez-Martinez J; Hernandez L; Zamorano L; Sloan A; Levin K; Lo S; Li Q; Diaz F
J Neurosurg; 2002 Dec; 97(5 Suppl):494-8. PubMed ID: 12507084
[TBL] [Abstract][Full Text] [Related]
39. Impact of the number of metastatic brain lesions on survival after Gamma Knife radiosurgery.
Bashir A; Hodge CJ; Dababneh H; Hussain M; Hahn S; Canute GW
J Clin Neurosci; 2014 Nov; 21(11):1928-33. PubMed ID: 25037311
[TBL] [Abstract][Full Text] [Related]
40. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
